The Board and Management
Ali Salanti is founder and CEO of VAR2 Pharmaceuticals. He holds a Ph.D. in medicine and is Professor at University of Copenhagen.
Executive chairman of the board
Dr. Mads Daugaard is co-founder and Executive Chairman of the Board of VarCT Diagnostics and VAR2 Pharmaceuticals.
Professor Peter Schröcksnadel joined the Board of VAR2 Pharmaceuticals in 2016 and co-founded VarCT Diagnostics in 2017. He brings extensive business experience and vast networks from decades in in the broadcasting/marketing industry and international alpine skiing organisations.
THOR G. THEANDER
Professor Thor Theander is co-founder and member of the Board of Directors of VAR2 Pharmaceuticals. He is specialised in Malaria research and was instrumental in the original discoveries leading to the development of the VAR2 technology.
Professor Sorensen is co-founder and member of the Board of Directors of VAR2 Pharmaceuticals. He is a molecular pathologist and cancer biologist, specializing in the genetics and biology of pediatric cancers.
VAR2 Pharmaceuticals ApS
Ole Maaløes Vej 3
DK-2200 Copenhagen N
T: +45 78 70 19 00